Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Orthofix Medical Inc
F:OM2
Orthofix Medical Inc
F:OM2
Price:
8.05
EUR
3.21%
Market Closed
Market Cap:
€302.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Orthofix Medical Inc
F:OM2
|
US |
|
T
|
Toll Brothers Inc
F:TLK
|
US |
|
C
|
Continental AG
F:CON
|
DE |
|
C
|
CME Group Inc
F:MX4A
|
US |
|
S
|
Shell PLC
AEX:SHELL
|
UK |
|
S
|
Singapore Airlines Ltd
OTC:SINGF
|
SG |
|
M
|
Moody's Corp
XMUN:DUT
|
US |
Wall St Price Targets
OM2 Price Forecast
Based on 7 analysts
Based on 7 analysts
+149% Upside
from
€8.05
today
Orthofix Medical Inc (OM2)’s 12-month stock price forecast through September 2027 has a consensus target of €20.05, implying 149% upside. The forecast is based on price targets from 7 Wall Street analysts.
OM2 Analyst Rating
No ratings yet
No ratings yet
Orthofix Medical Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is OM2's stock price target?
Price Target
20.05
EUR
20.05
EUR
According to Wall Street analysts, the average 1-year price target for OM2 is 20.05 EUR with a low forecast of 18.32 EUR and a high forecast of 22.22 EUR.
What is the Revenue forecast for Orthofix Medical Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 5%.
What is the Gross Profit forecast for Orthofix Medical Inc?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 4%. The projected CAGR for the next 3 years is 7%.